Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Post by canadafanon Dec 28, 2022 8:26pm
375 Views
Post# 35194606

I’m around…just busy with Christmas & family stuff

I’m around…just busy with Christmas & family stuffI check in for snipets of logic on this site, as others.
been busy with Christmas, family & on- going medical issues.
i did comment, the period between Christmas & newyears is ripe for buying opportunities.
few are watching. Like myself,....
I look forward to a strong recovery & news flow , January.
Some expected & commented on the company web site.
The overall markets were down today. My hope & expectation...news flows will come forward.
Not until after 1st week of Jan.
leaving this as a dead zone of trading.
Over the years, I have seen this opportunity with even solid blue chip stocks.
I do have a challenge for any & all posting on here.

If you can not post one positive comment about Onc, Then perhaps it's time you sell & move on.
Ad hominem, discussions add no value to this board, & certainly not ONC as A Compnay.
Back to the point:
Onc has very recently received fast track approval in a co- trial with Roche.
The pancreatic cancer results were above expectations.
the China partner has displayed success & ready to move to phase 3.

wishing everyone a happy & prosperous 2023.


<< Previous
Bullboard Posts
Next >>